21 Introduction: Detecting laboratory cross-contamination and mixed tuberculosis infection are 22 important goals of clinical Mycobacteriology laboratories. 23 Objectives: To develop a method detecting mixtures of different M. tuberculosis lineages in 24 laboratories performing Mycobacterial next generation sequencing (NGS). 25 Setting: Public Health England National Mycobacteriology Laboratory Birmingham, which performs 26 Illumina sequencing on DNA extracted from positive Mycobacterial Growth Indicator tubes. 27 Methods: We analysed 4,156 samples yielding M. tuberculosis from 663 MiSeq runs, obtained 28 during development and production use of a diagnostic process using NGS. Counts of the most 29 common (major) variant, and all other variants (non-major variants) were determined from reads 30 mapping to positions defining M. tuberculosis lineages. Expected variation was estimated during 31 process development. 32
INTRODUCTION 45
Mycobacterium tuberculosis is an organism which has co-evolved with humans during the early 46 migrations of modern man, diverging from a common M. tuberculosis ancestor about 75,000 years 47 ago (1). Distinct lineages, corresponding to evolution occurring during these early migrations, are 48 readily identified by next generation sequencing (NGS), with each lineage characterised by ancient 49 single nucleotide variants (SNV) which define deep branches in the M. tuberculosis phylogeny (1, 2) . 50
Multiple M. tuberculosis lineages: Infection by multiple lineages of TB is well described, and has 51 been detected by observing mixed results on fractional sequencing (e.g. spoligotyping, MIRU-VNTR) 52 and validated by characterisation of multiple individual picks from solid media (3). Multi-lineage 53 infection is characterised by isolates differing by many hundreds of SNVs, in which respect it differs 54 from the increasingly recognised and more common in-host microevolution (4). Reported rates of 55 mixed infection vary markedly as reviewed (3, 5) , with between 10 and 30% reported in areas of 56 current (5-7) or historical (8, 9) high prevalence. Much lower rates are reported in low incidence 57 countries (3), although systematic under-detection is likely to occur due to both to the limited 58 representation of bacteria in single sputum samples of pulmonary disease, and to the decrease in 59 diversity occurring during differential strain growth in broth culture (10) . 60
Implications of mixed infection: Mixed infection, assessed by either MIRU-VNTR polymorphisms (7) 61 or by heterogeneity in drug susceptibility testing (11), is independently associated with reduced drug 62 treatment response, so there are compelling clinical reasons to try to identify it. There are also 63 important technical implications of isolating mixed TB strains from a culture. Firstly, such a finding 64 may reflect cross-contamination within the laboratory (3). Secondly, mixed infection complicates 65 the interpretation of drug resistance tests, whether phenotypic or genotypic, as one or other co-66 infecting strain may dominate the results from these tests. Thirdly, it complicates the understanding 67 of relatedness when techniques such as SNV distance computation are applied, as these generally 68 assume a single sequence is present when base-calling (5, (12) (13) (14) , marking mixed sites as uncertain. 69
Maximal likelihood tree drawing algorithms assume such 'uncertain' sites contain no information 70 and impute a single nucleotide at each of such positions, an approach which may be inappropriate in 71 the presence of mixtures. 72
Increasingly, NGS based species and resistance determination is becoming routine in 73
Mycobacteriology laboratories, and has been deployed in reference laboratories in England (15, 16) . 74
As part of the quality control and accreditation of the routine process now operating in these 75 laboratories, we describe an approach to identifying mixed samples using Illumina next generation 76 sequencing data, illustrating its use by studying over 4,000 consecutive positive cultures from a 77 Bioinformatic processing
95
The routine bioinformatics pipeline deployed by Public Health England has been previously 96 described (15). Briefly, reads were first processed using the Mykrobe predictor tool, which identifies 97
Mycobacterium tuberculosis using species specific k-mers (17). Specimens identified as containing 98 M. tuberculosis were further processed (16), mapped to the H37Rv v2 genome (NC_000962.2) (18), 99 as described (16), and vcf files generated using Samtools mPileup, with additional basecalling using 100 GATK VariantAnnotator v2.1. A consensus base is called from high-quality bases provided one base 101 accounts from >90% of the pileup; otherwise, the base is recorded as uncertain ('N') (15). In this 102 analysis, high quality base counts (identified by the BaseCounts VCF tag) were extracted and 103 summarised using code available at https://github.com/davidhwyllie/VCFMIX. 104 nucleotide set, in one particular clade, one nucleotide is uniquely present (i.e. is not present in any other of the known clades). These sets contain a median 108 nucleotide positions (range 1 -898). 109
Nucleotides identifying lineage
In this analysis, we considered 55 branches, excluding branches 1.2, 3.1, 3.1. 2, 4.1.2, 4.3.4.2.1, 4.6 110 and 4.7 because they contain fewer than 20 positions, making estimates of minor variation in these 111 positions less reliable than estimates in other branches. We identified lineage using consensus 112 basecalling in these 55 branches. If the signature SNV of a branch was called as uncertain, we called 113 only to the level of the branch deeper (i.e. closer to the root) than the uncertain call. If more than 114 one different lineage defining variant was called, or we could not call any lineage defining positions, 115 we reported the samples as 'lineage not defined '. 116 Estimation of the minor variant frequency within a set uniquely define these lineages will be mixed (depicted in Supplementary Figure 1C ); there will be a 128 minimum of two and maximum of eight sets affected (e.g. a Lineage 5/7 mixture will mix two sets of 129 lineage defining nucleotides, a 2.1/4.2.1 will mix five sets, and a 4.1.1.1 / 3.1.2.1 mixture will mix 8 130 sets). Only if more than two samples are mixed will more than 8 sets be mixed. In this work, we 131 describe two metrics reflecting mixing. Having computed the minor allele frequency estimates, p 1, 132 p 2 , .. p 55 we can sort these in descending order, identifying the sets with the highest and lowest 133 minor allele frequencies. We then estimate the minor variant frequency across the nucleotides in 134 the top two (F2 metric) and lowest 47 sets (F47 metric) as described above. The underpinning 135 assumptions are that mixtures of biological origin are most likely to occur between two lineages, and 136 therefore F2 is the most sensitive metric for identifying these. Since between two and 8 sets will be 137 mixed in such genuine co-infections, then the lowest 47 (55 -8) sets will not be mixed, and thus the 138 F47 metric is more sensitive for identifying laboratory contamination involving more than two 139 samples. 
RESULTS

150
Samples studied 151 4,156 samples were included since they (i) were identified using MyKrobe (17) as belonging to the 152 M. tuberculosis complex, and (ii) had at least 0.5 x 10 6 read pairs mapped to the H37Rv reference 153 genome, a criterion reflecting successful DNA extraction and sequencing. These sequences were 154 highly diverse, originating from six branches of lineage 1 (n=320), five branches from lineage 2 155 (n=278), five branches of lineage 3 (n=1,010), thirty lineage 4 branches (n=2,266). 106 samples were 156 from M. bovis or africanum, and 176 did not have their lineages defined. 157
The laboratory processes operated under three different phases: in the first, development, 158 laboratory processes were being actively refined; in the second, pre-production, laboratory 159 processes were fixed and controlled by standard operating procedures, with version controlled 160 changes. The third production state was similar to the second, except that the process had received 161 ISO15189 accreditation. 162 Variation in lineage defining positions in H37Rv controls 163 The F2 mixture metric reflects the estimated mixture in the two most mixed lineage defining sets; in 164 the H37Rv controls, this follows a distribution skewed to the right (Figure 2A ). The MiSeq runs with 165
H37Rv controls with F2 mixture metrics in the top 5% ( Fig We ordered specimens first by the order of the plates analysed and the order in which the 174 bioinformatics processing was completed, which is the order that an automated quality control 175 monitoring system would encounter output. During the Development phase (Fig. 3) , blocks of 176 samples derived from runs with elevated mixtures in the H37Rv control are seen (red bars in Fig. 3A) , 177 coincident with clear increases in both F2 and F47 metrics (Fig. 3B, C) , reflecting elevations in mixed 178 bases across most or all lineage defining positions (Fig. 3D ). These blocks of samples typically span 179 multiple MiSeq runs (Fig 3A,B) . In addition to the blocks of samples with elevated F2 and F47 180 metrics, we also observed small numbers of single samples with elevated F2, but not F47, metrics 181 ( Fig. 3B, Arrow) . This latter pattern is expected in cases of inter-lineage mixtures of only two 182 samples (Supp. Fig 1, and Methods) . These patterns were also seen in the subsequent phases 183 ( Supplementary Figures S2-5, yellow dots) . 184
Mixtures of multiple lineages are common 185 Based on the pattern observed in the Development phase, we categorised samples as having one of 186 (i) neither F2 nor F47 raised, (ii) raised F47, or (iii) raised F2 without raised F47. We defined a raised 187 F2 and F47 as more than 10x and 5x the respective median metric during Development in all control 188 and clinical samples, cutoffs which correspond to 4.7% (F2) and 0.2% (F47) minor variant frequencies 189 across the relevant lineage-defining sets, respectively. In the Pre-production and Production phases, 190 F2 and F47 values below these thresholds (reflecting unmixed samples) were observed in 97.5% of 191 the samples studied, raised F47 and F2 values (reflecting a mixture of multiple samples) in 2. 5%, 192 while six samples (0.001%) had raised F2 but normal F47 values (Table 2) . 193 Isolated F2 metric elevation is rare 194 Isolated elevation of F2 is expected if bacteria from two different lineages are mixed. In Fig. 4, we  195 show the minor variant frequencies from all samples from the six individuals with raised F2, but 196 normal F47, metrics. In one case, patient 3, two technical repeats of the same sample (#2) showed 197 the same pattern, as did a separate sample taken contemporaneously. In other cases (patients 1, 5, 198 6) the mixed pattern was only observed in one out of two positive samples taken on the same day, 199 and in two cases (2, 3) only a single sample was positive. Thus, between 1 and 6 samples of the 200 4,156 studied may truly reflect mixed co-infections. 201
Impact of inter-lineage variation on basecalling 202
One obvious question is whether very low level cross-contamination impacts the consensus 203 sequence which can discerned from the pileup. As cross-contamination increases, at some point 204 minor variant frequencies in some parts of the genome will start to rise above the 10% cutoff 205 specified by the basecalling algorithm. The numbers of uncalled bases will then rise; this 206 relationship can be observed in Figure 5 : the number of uncallable bases rises rapidly when F47 207 exceeds the cutoff value, but only slowly below it. Below the cutoff value of 4.7% (red line in Fig. 5) , 208 which is 10 times the median (black line in Fig. 5 ), the number of uncallable bases increased by 1.25 209 fold (95% CI 1.22, 1.28) for every 10-fold increase in F47; above the cutoff, the corresponding 210 increase was 9.24 (95% CI 5.5, 11.2). 211
212
DISCUSSION
213
In this work, we describe methods for monitoring the presence of mixtures of Mycobacterium 214 tuberculosis of different lineages. It assumes that multiple lineages and sublineages of M. 215 tuberculosis are being sequenced contemporaneously; this is the case in our setting, and is also true 216 globally (19, 20) . Using single nucleotide variants, each of which uniquely defines a branch in the 217 phylogenetic tree of M. tuberculosis, we can show two patterns of mixtures. The first, which 218 occurred in about 2.5% of samples during the pre-production and production phases of our project, 219 is indicative of multiple samples being mixed together, since mixtures are seen in most or all of the 220 lineage defining branches. This occurred in batches, was characterised by cross-contamination at 221 levels of less than 1%, and can be monitored by a metric we term F47. This pattern likely reflects 222 process failures. The strength of the F47 metric is that the depth analysed is very high, as about 223 5,000 nucleotides typically contribute across the lineage-defining sets included in it. If there is a 224 sequencing depth of 50-100 at each of these, the effective sequencing depth analysed is of the order 225 of 25,000 -50,000, making detection of minor variation at sub-1% levels readily feasible with high 226 statistical confidence. 227 Such low level cross-contamination, as observed during our production process and illustrated in 228 Supplementary Figures 2-4 , is likely to have minimal influence on inference drawn from the 229 sequence, unless highly sensitive assays for heteroresistance are required. A sensitive metric such as 230 F47 will, however, allow early detection of emerging problems and allow review of process, as part 231 of continuous quality improvement. 232
A second class of mixture, which we found was rarely detected in this setting, is compatible with co-233 infection with two organisms of differing lineage within the patient. This kind of mixture is clinically 234 relevant (7, 11), and may be under-detected using the laboratory process we describe here, since 235 culture based amplification can reduce diversity in the sample inoculated (10). Its frequency may 236 rise if direct-from-sample sequencing is employed, or if samples from high-endemicity areas are 237 studied, but here we identified only one probable case of such mixtures, and five other possible 238 cases. Confirmatory approaches are available: microbiological techniques conducted separately on 239 multiple picks from the same samples have been used as validation(3); a limitation of this study is 240 that we could not undertake such work as only multiply sub-cultured stored isolates exist for 241 historical samples. Techniques for reconstructing the contributing sequences also have been 242 described in detail (21-23), and we did not study them here. Another limitation is that we were not 243 able to consider six of the lineage defining sets in Coll et al because they covered <20 nucleotide 244 positions and therefore we considered that they did not contain sufficient information to be used in 245 F2 or F47 metrics. A consequence is that our method would not identify mixtures of samples if they 246 only involved mixtures in these excluded branches. 247
The clinical of use of bacterial genome sequencing is rising (16, 17, 24) , and given the importance of 248 M. tuberculosis and the complexity of treatment, M. tuberculosis has been one of the first organisms 249 tackled (15). The processes followed involve multiple steps at which the opportunity for cross-250 contamination exists. The availability of tools monitoring critical aspects of laboratory process is 251 required for accreditation under ISO15189, and the F2 and F47 metrics described here will 252 contribute to this. 253 
